Over the past 90 days, 15 of the 20 worst-performing non-leveraged exchange traded funds are energy funds. Underscoring the weakness in the healthcare sector, four of the other five offending ETFs are healthcare funds.
Year-to-date, the Healthcare Select Sector SPDR (NYSE: XLV), the largest healthcare ETF by assets, is down 8.5 percent. That confirms XLV's best-to-worst slide. From 2013 through 2015, XLV was one of the top-performing SPDRs as healthcare played a significant part in lengthening the bull market that started in March 2009.
Diversified healthcare ETFs, such as XLV, benefited from surging biotechnology stocks, but have recently succumbed to that industry's doldrums. Remember the four lagging healthcare funds mentioned at the start of this piece? All are biotech ETFs and ...
/www.benzinga.com/general/biotech/16/02/6479327/slump-could-be-healthcare-etf-buying-opportunity alt=Slump Could Be Healthcare ETF Buying Opportunity>Full story available on Benzinga.com
More...